Christopher Jean-Louis, DO
Surgical Oncology · Stockbridge, GANPI 1477964278
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for surgical oncology clinicians in GA, where the typical reported total is $2,336.
Across 24 payments — averaging $26.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$135
- AbbVie$99
- Hologic Sales And Service, LLC$71
- Molli Surgical (US) Inc$59
- Bard Peripheral Vascular, Inc.$41
- Acera Surgical, Inc.$28
- plus $194 from 10 others
What the payments were for
- Food & beverage$628100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 5 | $135 |
| AbbVie | 1 | $99 |
| Hologic Sales And Service, LLC | 4 | $71 |
| Molli Surgical (US) Inc | 1 | $59 |
| Bard Peripheral Vascular, Inc. | 2 | $41 |
| Acera Surgical, Inc. | 1 | $28 |
| Davol Inc. | 1 | $25 |
| Innovation Technologies Inc | 1 | $25 |
| Avanos Medical | 1 | $24 |
| Acell, Inc. | 1 | $24 |
| Stryker | 1 | $22 |
| Chiesi USA, Inc. | 1 | $19 |
| Dilon Technologies, Inc. | 1 | $16 |
| CSL Behring | 1 | $15 |
| Hologic Inc | 1 | $12 |
| Baxter Healthcare | 1 | $11 |
How this compares
$628 in reported general payments places this provider in the 30th percentile of 43 surgical oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $131 |
| Ondansetron OdtOndansetron | 26 | $80 |
| Gabapentin | 38 | $75 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $68 |
| Tramadol Hcl | 26 | $49 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Stockbridge
- Eddie AbdallaAtlanta$34K
- Atuhani BurnettAtlanta$23K
- Anita JohnsonWoodstock$18K
- Danny YakoubAugusta$17K
- Nicole KounalakisAtlanta$14K
- Sartaj SangheraMarietta$10K
- Barry RosemanAtlanta$10K
- Arnold ConfortiMacon$9K
- James GarberSavannah$7K
- James GriffinAthens$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.